CD4 and influenza: Previous studies have shown that APβG exhibited adjuvant activity and induced resistance against influenza; however, further investigation into the underlying mechanisms revealed that the intraperitoneal administration of APβG increased the serum level of IL-18 and the number of splenic IFN-γ-producing CD4-positive cells after influenza A viral infection.